Back
Pyxis Oncology, Inc. 10K Form
Sell
25
PYXS
Pyxis Oncology, Inc.
Last Price:
$4.33
Seasonality Move:
63.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PYXS News And Ratings
See the #1 stock for the next 7 days that we like better than PYXS
PYXS Financial Statistics
Sales & Book Value
| Annual Sales: | $16.1M |
|---|---|
| Cash Flow: | $-13.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.11 |
| Price / Book: | 3.91 |
Profitability
| EPS (TTM): | -1.59170 |
|---|---|
| Net Income (TTM): | $-97.1M |
| Gross Margin: | $12.7M |
| Return on Equity: | -90.91% |
| Return on Assets: | -67.69% |
Pyxis Oncology, Inc. Earnings Forecast
Key Pyxis Oncology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for PYXS is 78.59%.
-
The Selling, General & Administrative Expenses for PYXS have been equal to 157.44% of Gross Profit Margin.
-
The Research & Development expenses have been 355.18% of Revenue.
-
The Net Earning history of PYXS is -478.95% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Pyxis Oncology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PYXS |
| Website: | pyxisoncology.com |
Debt
| Debt-to-Equity Ratio: | 0.28 |
|---|---|
| Current Ratio: | 4.29 |
| Quick Ratio: | 4.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PYXS Technical Analysis vs Fundamental Analysis
Sell
25
Pyxis Oncology, Inc. (PYXS)
is a Sell
Is Pyxis Oncology, Inc. a Buy or a Sell?
-
Pyxis Oncology, Inc. stock is rated a SellThe current Pyxis Oncology, Inc. [PYXS] share price is $4.32. The Score for PYXS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.